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ABSTRACT
Candidemia is a significant cause of bloodstream infections (BSI) in nosocomial settings. 
The identification of species can potentially improve the quality of care and decrease human 
mortality. Quantitative PCR (qPCR) was evaluated for Candida albicans detection using 
culture suspensions containing C. albicans, spiked human blood, the cloned qPCR target 
fragment (ITS2 region) and the results of these assays were compared. The assays showed a 
good detection limit: C. albicans DNA extracted from yeast (sensitivity 0.2 CFU/µL), spiked 
human blood (sensitivity 10 CFU/mL), and cloned fragment of ITS2 region (sensitivity 
20 target copies/µL). The efficiency of ITS2 fragment-qPCR ranged from 89.67 to 97.07, and 
the linearity (R2) of the standard curve ranged from 0.992 to 0.999. The results showed that 
this ITS2-qPCR has a great potential as a molecular prototype model for the development 
of a test to be applied in clinical practice, greatly reducing the time of candidemia diagnosis, 
which is extremely important in this clinical setting.
KEYWORDS: Candida albicans. Candidemia. Detection. Invasive candidiasis. ITS2. 
Quantitative PCR. 
INTRODUCTION
Candidemia is the fourth most common cause of bloodstream infections (BSI) 
in nosocomial settings, with up to 50% of episodes occurring in intensive care 
units (ICU)1. Patients with invasive candidiasis (IC), even receiving antifungal 
therapy, have a mortality rate of 40%2. Furthermore, candidemia increases the 
hospital length of stay and the total cost of medical care3. Girão et al.4 from 
Universidade de Sao Paulo (USP), evaluated nosocomial candidemia in an ICU 
at Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao 
Paulo (HCFMUSP) for seven years, and they assessed 8.3 to 10.8 cases of BSI 
of 1,000 patients per day, and 5.6% of the cases were caused by Candida sp. 
The authors observed that C. albicans caused the majority of infections (40%), 
followed by C. tropicalis (34%), C. parapsilosis (18%), C. krusei (3%), and 
C. guilliermondii (1%)4.
The diagnosis of Candida sp. BSI is challenging, and, in general, takes place in 
the later stages of the disease. The blood culture is currently the gold standard for 
the diagnosis of IC; however, it has low sensitivity, and takes 48-96 h to identify the 
species5. The need of new tools for the diagnosis of candidemia is important due to 
the low sensitivity of blood culture, as only about 50% of all cases of candidemia are 
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detected6. Non-culture methods could successfully increase 
the sensitivity of the early diagnosis of IC7.
Quantitative PCR (qPCR) is considered a sensitive and 
accurate technique. The main advantage of this technique 
is the ability to generate quantitative data, in contrast to 
qualitative data generated by conventional PCR. Among the 
most promising targets for the diagnosis of invasive fungal 
infections by qPCR, the ITS (Internal Transcribed Spacer) 
region is part of the ribosomal RNA (rDNA) gene complex 
and has been used as a target in candidemia diagnosis by 
PCR. It is a non-coding region, and the genomic sequences 
are present in around 55 copies per haploid genome8.
The aim of this study is to evaluate an in-house qPCR 
specifically directed to C. albicans, applying a standard 
curve of a cloned fragment of the ITS2 region as a reference 
in future qPCR assays for the detection and quantification 
of C albicans in human blood. This new assay should have 
a good detection limit, reproducibility and specificity.
METHODS
This study was approved by Comite de Etica em 
Pesquisa da Faculdade de Medicina da Universidade de 
Sao Paulo (Process Nº 1.856.53). Blood samples from 
healthy participants were collected after the signature of 
an informed consent. The samples were stored at 4 °C 
until processing. 
Yeast cells of C. albicans (ATCC 90028) were cultivated 
in Sabouraud agar plates (37 °C; 24 h). They were added 
in a solution of Tris-HCl-EDTA (TE) and counted in a 
Neubauer chamber; subsequently, they were adjusted 
to a concentration of 108 colony forming units per mL 
(CFU/mL).
Three sets of experiments were performed:
1) C. albicans suspension in a concentration of 108 CFU/mL
For DNA extraction, the pellet containing the yeasts was 
incubated at 37 °C for two h in TE (Tris HCl 10 mM pH 8.0; 
EDTA 2 mM pH 8.0) and 200 U of Lyticase (Sigma-Aldrich, 
Missouri, USA). The remaining steps were performed 
by using the QIAamp® DNA Blood Mini Kit (QIAGEN 
Inc., Hilden, Germany), following the manufacturer’s 
instructions. The sample was eluted in 100 µL of an elution 
buffer (QIAGEN). DNA concentration was estimated by 
using a UV spectrophotometer (Nanodrop LITE, Thermo 
Fisher Scientific Corp., Wilmington, Delaware, USA). A 
ten-fold dilution series, from 106 to 10-3 CFU/µL of the 
product of extraction, were submitted to amplification.
2) Spiked blood samples with C. albicans 
C. albicans yeasts were added to non-infected human 
blood in a concentration of 107 CFU/mL, and immediately 
homogenized. The spiked blood was then used to produce 
a ten-fold dilution series (107 to 100 CFU/mL). To other two 
blood aliquots of 1 mL each, 2 and 5 yeasts were added. An 
extraction control and blood without yeasts were processed 
along with the spiked curve dilutions
DNA extraction was performed by following 
the methodologies described previously9, with some 
modifications: each 1 mL of the spiked blood samples 
was initially treated with the blood lysis buffer (NH4CL 
155 mM; KHCO3 10 mM; EDTA 1 mM pH 7.4), followed 
by a centrifugation at 1,200 g for 15 min; the pellet was 
incubated at 37 °C for 2 h with Nucleo Lysis Buffer (Tris 
HCL 10 mM pH 8.0; NaCL 0.4 mM; EDTA 2 mM pH 8.2), 
and 200 U of Lyticase (Sigma-Aldrich, Missouri, USA) 
were added. The remaining steps were performed by 
using the QIAamp® DNA Blood Mini Kit, following the 
manufacturer’s instructions.
3) Cloning the fragment of the ITS2 region 
A 108-bp DNA fragment of ITS2 region was amplified from 
a C. albicans strain (Accession Nº KT876203.1), using the 
primers forward 5'- GGGTTTGCTTGAAAGACGGTA -3' 
and reverse 5'-TTGAAGATATACGTGGTGGACGTTA-3' 
in the qPCR10. Then, the PCR product was cloned into the 
plasmid vector pJET 1.2/blunt, using the CloneJET PCR 
Cloning Kit (Thermo Fisher Scientific Corp., Wilmington, 
Delaware, USA), following the manufacturer’s instructions. 
The pJET 1.2/blunt of the ITS2 region linked to the 
plasmid was purified using the miniprep technique11. 
The DNA concentration was estimated by using a UV 
spectrophotometer (Nanodrop LITE, Thermo Fisher 
Scientific, Wilmington, Delaware, USA). In order to 
generate standard curves for the quantitative assays and 
to assess the amplification efficiency, a ten-fold dilution 
series of the pJET 1.2/blunt of the ITS2 region in the 
plasmid were prepared in 10 mM Tris-EDTA buffer (2 x 109 
to 2 x 100 copies/µL) and stored at −80 °C until use. To 
minimize contamination, the preparation of the pJET 1.2/
blunt of the ITS2 region plasmid dilutions was carried out 
in a separate room of the laboratory.
The lowest concentration of C. albicans detected by 
qPCR was the detection limit, which was estimated by the 
dilution series, tested in three sets of experiments.
The qPCR assays were performed in 20 µL of total 
volume containing 10 µL of 2 X Power SYBR Green PCR 
Master Mix (Applied Biosystems, Carlsbad, California, 
USA), 0.2 mM primers (region ITS-2) and 5 µL of each 
DNA sample. A StepOne Plus Real Time PCR System 
(Applied Biosystems, Carlsbad, California, USA) was used. 
The cycling conditions consisted of an initial denaturation 
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step at 95 °C (5 min), followed by 40 cycles at 95 °C (30 s), 
58 °C (30 s), and 72 °C (30 s), and a final dissociation step 
at 56-95 °C with a heating rate of 0.3°C/s.10 To estimate the 
equivalence between CFU and fentograms (fg) a previously 
reported methodology was followed12.
The assay reproducibility in detecting the cloned ITS2 
fragment and spiked blood samples was evaluated in 15 
independent assays: the first included ten assays with ten-fold 
dilution series of the cloned fragment (2 x 109 to 100 copies/
µL) and the second 5 assays with ten-fold dilution series 
of spiked blood (107 to 100 CFU/mL). Both assays were 
performed in different days under the same conditions.
The qPCR specificity was evaluated by testing DNA 
samples from other Candida species, other fungi and 
bacteria (C. glabrata, C. parapsilosis, C. tropicalis, 
C. krusei, C. dubliniensis, Enterococcus faecalis, 
Pseudomonas aeruginosa, Staphylococcus aureus, 
Streptococcus agalactiae, Escherichia coli; Rhodotorula 
sp, Cryptococcus neoformans, Histoplasma capsulatum and 
Fusarium sp) in a DNA concentration of 5 ng/reaction. As 
the positive control for these reactions, C. albicans DNA 
was used at concentrations of 0.05 and 5 ng/reaction. 
In addition, two negative controls (No Template Control 
- NTC) were included in each assay: one reagent control 
and one control to investigate contamination during the 
application of the standard curve samples.
The SPSS Statistics 17.0 software (SPSS Inc., Chicago, 
Illinois, USA) was used to determine the mean values and 
the standard deviations based on independent experiments 
for each set.
RESULTS AND DISCUSSION
For each of the two standard curves, five independent 
experiments were performed from a dilution series of 
spiked human blood, and ten independent experiments 
were performed from the cloned fragment of C. albicans, 
respectively.
Standard TS2 curves generated by ten-fold dilutions series 
of DNA from 2 x 109 to 2 x 100 copies/µL concentrations 
showed a perfect agreement in all ten independent qPCR 
assays. The assays demonstrated high efficiency (between 
89.03% to 101.46%), and the other critical parameter 
evaluated, the linearity R2 was between 0.996 ± 0.003 
(Table 1). The detection limit of the cloned ITS2 target 
indicated a mean Ct value of 32.97±0.99, corresponding 
to 20 copies/µL (Table 2 and Figure 1A). These results are 
similar to the other experiment in which the detection limit 
was 80 copies/mL in serum or plasma samples from IC 
patients comparing the samples to a standard curve generated 
by diluted plasmids from 108 to 101 copies/reaction13.
The detection limit observed in qPCR assays with DNA 
samples of C. albicans from culture was 10-1 CFU/µL, 
which corresponds approximately to 5 fg/reaction (Table 2 
and Figure 1B). This value is compatible with the results 
found in the limit dilution of the cloned sequence, i.e. 
20 copies/reaction, which corresponds approximately 
to one-fifth of a single CFU, considering approximately 
110 copies of the sequence/CFU (diploid genome)8. Other 
authors who used C albicans culture samples in qPCR 
observed similar results14,15.
Table 1 - qPCR performance to detect Candida albicans using 
cloned target sequence and spiked blood
Cloned target Spiked blood
Number of replicates 10 5
Slope (mean±SD) -3.452±0.115 -3.515±0.226
Linearity (R2) 0.996±0.003 0.997±0.002
Efficiency (%) 95.184±4.237 97.056±4.088
Table 2 - Performance of qPCR in three sets of experiments
Cloned Target* C albicans culture** Spiked Blood**
Copies/µL Ct Mean±SD CFU/µL Ct Mean±SD CFU/mL of Blood Ct Mean ± SD
2x10-1 ND 2x100 ND
2x100 ND ND 5x100*** ND
2x101 32.98 ± 1.00 10-1 33.70 ± 1.53 101 33.01 ± 0.65
2x102 29.54 ± 0.85 100 30.94 ± 0.73 102 34.70 ± 0.69
2x103 26.16 ± 0.86 101 27.13 ± 0.49 103 30.36 ± 1.55
2x104 22.40 ± 0.73 102 22.66 ± 0.68 104 26.33 ± 1.12
2x105 18.89 ± 0.92 103 18.35 ± 0.52 105 23.80 ± 0.81
2x106 15.38 ± 0.82 104 14.80 ± 0.48 106 20.32 ± 0.74
2x107 11.89 ± 0.77 105 11.02 ± 0.30 107 17.54 ± 0.84
* mean of ten assays; ** mean of three assays; *** mean of five assays; ND - non detected
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The present study allowed the detection of 10 CFU/mL 
of spiked blood samples in 100% of experiments and a 
detection of 5 CFU/mL in 50% of the same experiments. 
(Table 2 and Figure 1C). In the spiked blood samples, 
using similar methods, other researchers found 1 CFU/mL 
in 25%, 10 CFU/mL in 83%, and 100 CFU/mL in 100% 
of the experiments16. Previous studies have also shown 
the limit of detection of 10 CFU/mL of blood17-19. One of 
them compared extraction methods as well, observing that 
the QIAamp® DNA Blood mini kit (QIAGEN) was more 
sensitive than the other methods in serum samples spiked 
with C. albicans17. The qPCR assays with spiked blood were 
as efficient as the assays using the cloned target sequence, 
with the efficiency ranging from 89.67 to 97.07, and the 
linearity R2 from 0.992 to 0.999 (Table 1).
It is important to highlight that in all the assays carried 
out with cultured Candida albicans, cloned qPCR target 
sequence and spiked blood, the dissociation curves (melt 
curve) revealed the same temperature of 81.06 ± 0.19 ºC 
(Figure 1D). The qPCR had also a high analytical specificity 
as all other DNA samples from other fungal and bacterial 
strains tested negative (Figure 2). Similarly, a study using 
the TaqMan system and the same primers used in the present 
study did not find cross reactions with the 13 species of 
Candida tested, or with more than 20 tested species of other 
fungi and bacteria10.
One of the advantages of qPCR is the possibility of an 
earlier diagnosis (positive qPCR results were reported in 
patients who subsequently developed candidemia or clinical 
signs of IC). Moreover, the possibility of monitoring the 
persistence or resolution of the infection7 is also interesting 
for the patients’ follow-up A high sensitivity of qPCR was 
demonstrated when it was compared to blood cultures in 
patients with proven/probable or possible IC7. 
In a retrospective study, the authors have shown the 
ability of qPCR in detecting less than 5 CFU/mL in 23% of 
cultured peripheral blood samples from patients with known 
IC6, and the time required by the molecular technique for 
Figure 1 - Technical performance and detection range of the Candida albicans qPCR: A) Amplification curves of ten-fold dilutions 
of cloned targets ranging from 2 x 109 to 2 x 101 copies/µL; B) Amplification curves of ten-fold dilutions of cultures, ranging from 
105 to 10-1 CFU/µL; C) Amplification curves of ten-fold dilutions of spiked blood, ranging from 107 to 101 and 5 CFU/mL of blood; 
D) Dissociation curves for the amplifications observed in A, B and C, where the same Melting temperature of 81.06 ± 0.19 ºC was 
observed. The linearity R2 value was 0.996.
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diagnosis is still an advantage when comparing it with 
cultures, since blood cultures depend on the growing time 
of yeasts. 
Studies with clinical samples have shown that only 53% 
of positive cultures had fungal density lower than 1 CFU/mL, 
in the first culture-positive sample20, however, it is necessary 
to establish a relationship between the amount of CFUs 
present in the blood sample and the amount of CFUs 
that have grown in the culture plate. This correlation was 
demonstrated in a previous study involving experiments 
with spiked blood, and the authors pointed to a detection 
limit for C. albicans of 103 CFU/mL for aerobic and 101 to 
102 CFU/mL for anaerobic blood cultures21, which could 
explain the low sensitivity of the culture method in the 
detection of Candida sp. in blood samples.
Further studies are still necessary to improve and 
implement the qPCR technique, evaluating its impact on 
clinical practice. This study has shown that throughout the 
analyzed parameters it was possible to construct standard 
qPCR curves with cloned target sequences, reaching a good 
limit of detection, reproducibility and great specificity. The 
method used is a prototype strategy based on molecular 
technology for the development of future assays focused 
on the detection of C. albicans and other Candida sp in 
human blood to accelerate the identification of the yeast, 
allowing a rapid and more appropriate clinical intervention.
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